Leica Microsystems (Schweiz) AG: Observational study withdrawn (High-Grade Glioma (WHO III-IV), Cerebral Vascular Conditions Requiring Surgical Intervention)
Leica Microsystems (Schweiz) AG: Observational study withdrawn (High-Grade Glioma (WHO III-IV), Cerebral Vascular Conditions Requiring Surgical Intervention). Dated 2 days ago, it is inside the fresh trigger window. Score 70/100. As of 2026-11-04, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
Free preview: all 13 published fields of this record are shown below. Locked: 499 related ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | Leica Microsystems (Schweiz) AG |
| Sponsor type | Industry (pharma, biotech, medtech) |
| Study | Evaluation of Image Quality and Safety of the MyVeo Surgical Visualization Headset During Standard Neurosurgical and Reconstructive Procedures Using Compatible Microscopes. |
| NCT ID | NCT07164053 |
| Phase | Observational |
| Status | withdrawn |
| Conditions | High-Grade Glioma (WHO III-IV); Cerebral Vascular Conditions Requiring Surgical Intervention; Conditions Requiring Plastic and Reconstructive Surgery |
| Intervention types | device |
| Posted | 2025-09-09 |
| Planned start | 2026-10 |
| Event | Withdrawn before enrolling |
| Event date | 2026-11-03 |
| Last update posted | 2026-11-03 |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Leica Microsystems (Schweiz) AG
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock Leica Microsystems (Schweiz) AG + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-11-03
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (NONUS first): University of Oxford · DejthidaNathaphong · Eye & ENT Hospital of Fudan University · Shanghai First Maternal and Infant Health Hospital affiliate · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Wed, 04 Nov 2026 06:04:38 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Leica Microsystems (Schweiz) AG and 6,603 NONUS peers
- NONUS ClinicalTrialStartPulse records like this one: 6,603
- Timing: High: dated in the last 7 days
- Estimated pipeline if you contact every NONUS peer: $1,320,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
70 / 100 Score
- Posted in the last two weeks.
- Industry sponsor (buys outsourced services).
- Stopped early: budget and sites freed up.
What is the ClinicalTrialStartPulse record for Leica Microsystems (Schweiz) AG?
Leica Microsystems (Schweiz) AG's Observational study (NCT07164053) in High-Grade Glioma (WHO III-IV), first posted 2025-09-09: withdrawn before enrolling (2026-11-03), in an update posted 2026-11-03.
How does Leica Microsystems (Schweiz) AG compare to other ClinicalTrialStartPulse records?
It is fresh: dated 2 days ago, inside the window where early outreach matters most. Its Score of 70/100 puts it among the stronger signals in this feed.
Leica Microsystems (Schweiz) AG vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| Leica Microsystems (Schweiz) AG | NONUS | 2026-11-03 | ||
| Hoffmann-La Roche | NONUS | 1,800 | 96th | 2026-10-30 |
| Janssen Pharmaceutica N.V., Belgium | NONUS | 1,314 | 95th | 2026-11-03 |
| Janssen-Cilag International NV | NONUS | 135 | 68th | 2026-11-03 |
Related records
ClinicalTrialStartPulse: Observational ClinicalTrialStartPulse: Outside the US only
How to monitor Leica Microsystems (Schweiz) AG and peer observational records
Get new ClinicalTrialStartPulse records like Leica Microsystems (Schweiz) AG by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.